Retraction Note to: Neurotherapeutics https://doi.org/10.1007/s13311-020-00878-7
The Editor-in-Chief has retracted this article. Concerns have been raised about the data presented. The response from the authors to these concerns has shown that there are serious issues with the ethical oversight, the reporting and the availability of audited data for this clinical trial. The Editor-in-Chief therefore no longer has confidence in the results and conclusions presented. All authors disagree with this retraction.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.